Affiliation:
1. Department of Neurology, Cognitive Disorders and Dementia Center, Dong-A University College of Medicine, Busan 49201, Republic of Korea
2. Department of Nuclear Medicine, Dong-A University College of Medicine, Busan 49201, Republic of Korea
Abstract
Patients with mild cognitive impairment (MCI) have a relatively high risk of developing Alzheimer’s dementia (AD), so early identification of the risk for AD conversion can lessen the socioeconomic burden. In this study, 18F-Florapronol, newly developed in Korea, was used for qualitative and quantitative analyses to assess amyloid positivity. We also investigated the clinical predictors of the progression from MCI to dementia over 2 years. From December 2019 to December 2022, 50 patients with MCI were recruited at a single center, and 34 patients were included finally. Based on visual analysis, 13 (38.2%) of 34 participants were amyloid-positive, and 12 (35.3%) were positive by quantitative analysis. Moreover, 6 of 34 participants (17.6%) converted to dementia after a 2-year follow-up (p = 0.173). Among the 15 participants who were positive for amyloid in the posterior cingulate region, 5 (33.3%) patients developed dementia (p = 0.066). The Clinical Dementia Rating-Sum of Boxes (CDR-SOB) at baseline was significantly associated with AD conversion in multivariate Cox regression analyses (p = 0.043). In conclusion, these results suggest that amyloid positivity in the posterior cingulate region and higher CDR-SOB scores at baseline can be useful predictors of AD conversion in patients with MCI.
Funder
Dong-A University research fund
Reference34 articles.
1. Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline;Boyle;Neurology,2006
2. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment;Mufson;Exp. Neurol.,1999
3. Mild cognitive impairment: Clinical characterization and outcome;Petersen;Arch. Neurol.,1999
4. Sehar, U., Rawat, P., Reddy, A.P., Kopel, J., and Reddy, P.H. (2022). Amyloid Beta in Aging and Alzheimer’s Disease. Int. J. Mol. Sci., 23.
5. Neuropathologic features of amnestic mild cognitive impairment;Petersen;Arch. Neurol.,2006